TechHealth, Inc. has been acquired by One Call Care Management
TechHealth, Inc., a leading provider of cost containment services for workers’ compensation, has been acquired by One Call Care Management. Financial terms of this transaction have not been disclosed.
TechHealth uses its proprietary technology to provide cost containment solutions for physical therapy, equipment and device management, home health, diagnostics, and transportation and language services to insurance carriers, third party administrators and self-insured employers.
One Call Care Management, a portfolio company of Odyssey Investment Partners, is the nation’s leading provider of specialized cost containment services to the workers’ compensation industry. The acquisition of TechHealth provides One Call Care Management entry into the physical therapy market as well as the opportunity to integrate best-of-breed services, strategies and technologies in the other markets served by the companies.
One of Oaklins' teams in the USA served as financial advisor to the seller in this transaction.
Talk to the deal team
Michael Goldman
Oaklins TM Capital
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more